Abstract: Liquid nasal drug delivery has evolved from simple local therapies into a highly versatile platform supporting rapid systemic delivery, emergency rescue medications, and emerging CNS‑targeted treatments. As these applications expand, successful development increasingly depends on early, integrated alignment of formulation science, device selection, analytical control, and manufacturing strategy. In this article, sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úexperts Dr. Alan Watts and David Wilcox examine the current and emerging nasal delivery landscape and outline critical chemistry, manufacturing, and controls (CMC) considerations across development, scale‑up, and commercial production. Drawing on real‑world experience, the piece highlights practical strategies to reduce technical risk, support regulatory readiness, and enable robust, scalable liquid nasal drug products.

The CASSS Cell & Gene Therapy Products (CGTP) Symposium brings together leading scientists, regulators, and biopharma professionals to explore the latest advances in cell and gene therapy development. This multi-day program will focus on critical topics such as manufacturing, quality, and regulatory considerations, while fostering open dialogue that helps shape evolving global standards. Through expert presentations, roundtables, and networking opportunities, attendees gain valuable insights into emerging technologies, commercialization challenges, and innovative approaches driving the future of advanced therapeutics.

Date: June 9-11, 2026
Location: Bethesda North Marriott Hotel & Conference Center, Rockville, Maryland
Booth: #2

JOIN US!

Complete the form to schedule a meeting with our experts!

ABOUT CATALENT

sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Ú. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úhelps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úprovides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Útailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úsupplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matterâ„¢

Abstract:​ Modern drug development is being tested on two fronts: molecules are increasingly difficult to formulate, and global manufacturing routes are increasingly difficult to rely on. Poor water solubility and limited physical stability continue to slow many small‑molecule and peptide programs, while shifting trade policies and logistics constraints add cost and risk across fragmented supply chains. This executive summary explores how integrating large‑scale, domestic spray drying capacity earlier in development can help sponsors accelerate timelines, improve cost efficiency for high‑volume therapies, and reduce risk tied to international manufacturing disruption. It also outlines the role of spray drying in enabling spray‑dried amorphous systems and amorphous solid dispersions (ASDs), key scale‑up considerations, and why selecting a CDMO partner with the right capacity and scientific track record can help bridge feasibility to commercial execution.

The 14th Antibody Industrial Symposium (AIS2026) jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector, is the ideal conference for scientists, industrials, clinicians, and policy makers to exchange about therapeutic antibodies and more. This year’s 2-day program is organized into several tracks covering the hot topics in antibody, recombinant proteins, and other biopharmaceuticals research and development. Moreover, the program will allow opportunities for one-to-one meetings, companies to showcase new products and technologies virtually as well as dedicated time for business partnering.

Date: Jun 30-Jul 1, 2026
Location: The CORUM Congress Center Montpellier, France
Booth: 16

JOIN US!

Meet Catalent’s experts at AIS 2026 to explore how our integrated drug substance and drug product solutions can accelerate the development of therapeutic antibodies and complex biologics. Learn how our end‑to‑end capabilities, from cell line development through clinical and commercial manufacturing, help innovators reduce complexity and advance programs with greater speed and confidence.

Complete the form to schedule a meeting with our experts!

ABOUT CATALENT

sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Ú. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úhelps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úprovides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Útailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úsupplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matterâ„¢

The BIO International Convention is the world’s largest and most influential biotechnology event, bringing together more than 20,000 global industry leaders across biotech, pharma, investment, manufacturing, and healthcare innovation. Hosted by the Biotechnology Innovation Organization (BIO), this conference serves as a premier platform for networking, strategic partnerships, and business development, featuring thousands of one-on-one partnering meetings, educational sessions, and a global exhibition showcasing the latest advances in life sciences and biopharmaceutical innovation.

This event attracts decision-makers from across the biotech ecosystem, including emerging biotech companies, large pharmaceutical organizations, CDMOs, CROs, investors, regulators, and technology providers. With programming focused on areas such as cell and gene therapy, AI-driven drug discovery, biomanufacturing, clinical development, and global health, BIO International is recognized as a key destination for companies looking to accelerate innovation, build partnerships, and expand their presence within the global life sciences industry.

Date: June 22-25, 2026
Location: San Diego Convention Center, San Diego, California
Booth: #5423

JOIN US!

Meet the sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úteam at BIO 2026 to learn how we help biotech and pharmaceutical companies accelerate development and bring innovative therapies to patients faster. We partner with innovators across biologics, cell and gene therapy, oral technologies, and clinical supply services to solve complex development and manufacturing challenges — supporting the therapies and breakthroughs that matter most to patients worldwide.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS!

Date/Time: 2:30pm-2:40pm PT, Tuesday, June 23, 2026
Location: BPI Theater @ BIO 2026: Insider Interview
Speaker: John Tomtishen, Global Head of Cell Therapy Field Application Scientists and Strategic Alliances

NETWORKING EVENTS!

Cocktails & Connections

Join us Tuesday, June 23 from 5:00–6:30 PM at Booth 5423 for refreshments, networking, and conversations centered on championing the missions that matter.

ABOUT CATALENT

sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Ú. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úhelps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úprovides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Útailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úsupplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matterâ„¢

The ALS Drug Development Summit is a scientific conference that brings together leaders from biotech, pharma, academia and advocacy groups to accelerate the development of therapies for ALS and related conditions. It focuses on collaboration, sharing research insights and advancing clinical and translational strategies to improve patient outcomes.

Date: June 2-4, 2026
Location: Boston, Massachusetts, USA

JOIN US!

Join us at the ALS Drug Development Summit to learn how sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úcan support your drug development journey with our Zydis® ODT technology, which advances patient-centric therapies through enhanced ease of administration and improved adherence. Schedule a meeting today!

Complete the form to schedule a meeting with our experts!

ABOUT CATALENT

sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Ú. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úhelps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úprovides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Útailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úsupplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matterâ„¢

The ISSN Annual Conference and Expo brings together professionals, researchers, and industry leaders in sports nutrition to share the latest science, research, and practical applications in the field. The event features expert presentations, networking opportunities, and discussions aimed at advancing evidence-based sports nutrition and supplementation.

Date: June 17-19, 2026
Location: Westin Fort Lauderdale Beach Resort, Fort Lauderdale, Florida

JOIN US!

Stop by the sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿ÚSelf-Care table at ISSN to experience creatine soft chews built for performance without powder. See how format innovation is unlocking better consumer adoption and brand growth.

Complete the form to schedule a meeting with our experts!

ABOUT CATALENT

sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Ú. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úhelps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úprovides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Útailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úsupplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matterâ„¢

The European Pharma Outsourcing Summit is an executive-level event that brings together pharmaceutical leaders to explore strategies in outsourcing, contract manufacturing and supply chain optimization. It features expert-led discussions, case studies and networking opportunities focused on improving efficiency, compliance and collaboration across global pharma operations.

Date: June 17-18, 2026
Location: Düsseldorf, Germany

JOIN US!

Join sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úat the European Pharma Outsourcing Summit to explore how our advanced oral drug delivery technologies and manufacturing expertise can help accelerate your programs from concept to market. Our team is ready to collaborate on tailored solutions that support accelerated development and bring oral therapies to patients, faster.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS!

Date/Time: Thursday, June 18, 2026 at 9:15am
Title: Maximizing Value Through Strategic CDMO Partnership
Speaker: Dejan Lamesic Director, Product Development

In an increasingly complex pharmaceutical landscape, innovators need strategic partners who can deliver both speed and reliability across the product lifecycle. This presentation explores how a strategic CDMO partnership unlocks external value through seamless collaboration from early development to commercialization and beyond. Attendees will gain insight into leveraging advanced oral drug delivery technologies, streamlining technology transfer to enable efficient scale-up and how strong operational oversight across a global site network mitigates risk, safeguards timelines and ensures reliable supply. Join us to learn how an integrated CDMO approach can drive efficiency, reduce complexity and accelerate the path to market and to patients.

ABOUT CATALENT

sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Ú. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úhelps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úprovides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Útailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úsupplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matterâ„¢

The CRS Annual Meeting & Exposition brings together global experts in delivery science to share cutting-edge research, foster cross-sector collaboration, and explore innovations across academia, industry and healthcare. The event features scientific sessions, workshops, and networking opportunities designed to advance drug delivery technologies and multidisciplinary innovation.

Date: July 7-11, 2026
Location: Lisbon, Portugal

JOIN US!

Learn how sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úis advancing oral drug development and delivery of macromolecules with modified release technology, bioavailability enhancement and scientific innovation. Meet with our experts to see how we can support your next breakthrough to bring better treatment to market and to patients.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Karunakar Sukuru (Karu), R.Ph., Ph.D., Global Vice President, Pharma Product Development & Head of Scientific Advisory
Date/Time: Wednesday, July 8 at 9:00am
Title: Breaking the Injection Barrier Using Innovative Technologies for Oral Delivery of Midsize and Macromolecules

Oral delivery of macromolecules such as peptides and proteins remains a major challenge due to enzymatic degradation, poor permeability and instability in the gastrointestinal tract. Despite these barriers, oral administration offers clear advantages in patient convenience, adherence and cost reduction. This presentation explores formulation and delivery strategies used to enhance oral bioavailability of macromolecules, with emphasis on lipid-based formulations, enteric softgels and sublingual/buccal routes. Mechanistic considerations including protection from gastric degradation, promotion of solubilization and modulation of intestinal absorption pathways will be discussed. By aligning molecular properties with appropriate formulation and delivery strategies, oral administration may be achievable for a specific range of peptides and biologics, supporting patient-centric product design and lifecycle differentiation.

ABOUT CATALENT

sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Ú. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úhelps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úprovides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Útailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úsupplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matterâ„¢

Abstract: Spray drying has evolved beyond amorphous solid dispersions to become a scalable, versatile manufacturing platform for small molecules, peptides, biologics, and emerging modalities. This executive summary explores how advances in spray drying technology, modeling, automation, and process analytics are addressing long‑standing challenges in bioavailability, stability, and commercial scale‑up. Through real‑world examples and a focus on quality‑by‑design, simulation, and digitalization, the piece highlights how spray drying can accelerate development timelines, improve manufacturability, and support the transition to continuous pharmaceutical manufacturing.